Home » Topics » BioWorld Science

BioWorld Science
RSS

Class III antiarrhythmics from Mitsui Toatsu

March 15, 1996

Kirin to codevelop antiischemic drug candidate

March 15, 1996

Potassium channel openers from Nippon Kayaku

March 15, 1996

Ciba-Geigy claims renin inhibitors

March 15, 1996

Kyowa Hakko reports endothelin antagonists

March 15, 1996

Uriach antihypertensive drug update

March 15, 1996

Lercanidipine approval imminent

March 15, 1996

Lexipafant asthma trial update

March 15, 1996

Terumo TxA2/LTD4 antagonists for asthma

March 15, 1996

Fujisawa claims PDE IV/TNF inhibitors

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...